Drug Prices on the Rise: What Can Physicians Do?
/Inflation-adjusted drug prices are up 60% in 10-years, amidst continued pharma profitability.
Read MoreThe Dirty Secret Behind FDA's "Open Public Hearings"
/They are supposed to give the public a voice in the drug approval process, but they may have been co-opted by Pharma.
Read MoreSpike in Hepatitis C Infections May Be Side-Effect of Oxycontin Reformulation
/In 2010, oxycontin was reformulated to deter abuse. There may have been some nasty side-effects to that change.
Read MoreMore Pharma Money to Physicians --> More Opioid Deaths
/A new county-by-county study found that the more a pharmaceutical company markets opioids to physicians, the higher the overdose death rate is.
Read MoreOne Simple Trick to Save Medicare $1 Billion
/An article appearing in the Journal of the American Medical Association finds we are paying through the nose for combination pills.
Read MoreIf the Drug Doesn't Work, You Don't Pay: The Reality of Outcomes-Based Contracting
/Latest idea to reduce drug costs is a wolf in sheep's clothing.
Read MoreStudy Reveals Broad Mislabeling and Adulteration Among Selective Androgen Receptor Modulators (SARMs) Marketed as "Nutritional Supplements"
/Nearly half of the products analyzed contained no SARMs, and 4 out of 44 actually contained tamoxifen, a selective estrogen receptor modulator.
Read MoreDo Generic Medications Hurt Patients?
/A gift to Big Pharma this week as a study appearing in Circulation Cardiovascular Quality Outcomes appears to show that the introduction of generic drugs is associated with a spike in adverse events. For the video version, click here.
Read MoreWhat the Market Will Bear: Doc-to-Doc on Skyrocketing Drug Prices with Dr. Umesh Khot
/Dr. Umesh Khot is the Vice-Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at the Cleveland Clinic and the author of a research letter in the New England Journal of Medicine examining the effects of the astronomical price increases of isoproteronol and nitroprusside. In this doc-to-doc interview, Dr. Khot discusses the reasons the prices increased, the effects that had on utilization of the drugs, and the implications this has more broadly in our healthcare system.
Read More